The antiviral drug molnupiravir received regulatory approval for treating people … Continued
Reporting the phase 2 results from the UK AGILE CST-2 … Continued
A “game-changing” antiviral pill that is part of the AGILE … Continued
People across the south are being asked to play their part in helping vital research into new COVID-19 treatments.
A ground-breaking clinical trial platform being led by researchers at the Southampton Clinical Trials Unit is now recruiting patients through the NIHR Southampton Clinical Research Facility within the General Hospital.
The world’s most innovative treatments for COVID-19 will soon be … Continued
Vir Biotechnology, Inc. (Nasdaq: VIR) and GlaxoSmithKline plc (LSE/NYSE: GSK) … Continued